nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A Phase II Multicenter Study of Visilizumab, Humanized Anti-CD3 Antibody, to Treat Steroid-Refractory Acute Graft-versus-Host Disease
|
Carpenter, Paul A. |
|
2005 |
11 |
6 |
p. 465-471 7 p. |
artikel |
2 |
Bloodstream Infection after Umbilical Cord Blood Transplantation Using Reduced-Intensity Stem Cell Transplantation for Adult Patients
|
Narimatsu, Hiroto |
|
2005 |
11 |
6 |
p. 429-436 8 p. |
artikel |
3 |
Editorial board
|
|
|
2005 |
11 |
6 |
p. A5- 1 p. |
artikel |
4 |
Establishing a Platform for Immunotherapy: Clinical Outcome and Study of Immune Reconstitution after High-Dose Chemotherapy with Progenitor Cell Support in Breast Cancer Patients
|
Sportès, Claude |
|
2005 |
11 |
6 |
p. 472-483 12 p. |
artikel |
5 |
Incidence of Human Cytomegalovirus Infection in Patients with Refractory Solid Tumors Receiving Nonmyeloablative Allogeneic Stem Cell Transplants versus Recipients of Standard SCT for Hematologic Malignancies
|
Zambelli, A. |
|
2005 |
11 |
6 |
p. 423-428 6 p. |
artikel |
6 |
Intensive Therapy before or during the Conditioning Regimen of Allogeneic Marrow Transplantation in Adult Acute Lymphoblastic Leukemia Patients: We Must Choose to Reduce Toxicity—A Groupe Ouest-Est d’Etude des Leucémies et Autres Maladies du Sang Study
|
Deconinck, Eric |
|
2005 |
11 |
6 |
p. 448-454 7 p. |
artikel |
7 |
Masthead
|
|
|
2005 |
11 |
6 |
p. A4- 1 p. |
artikel |
8 |
Officers and Directors of ASBMT
|
|
|
2005 |
11 |
6 |
p. A8- 1 p. |
artikel |
9 |
Pulmonary Cytolytic Thrombi after Allogeneic Hematopoietic Cell Transplantation: A Further Histologic Description
|
Peters, Antoinette |
|
2005 |
11 |
6 |
p. 484-485 2 p. |
artikel |
10 |
Reduced-Intensity Allogeneic Stem Cell Transplantation in Adults and Children with Malignant and Nonmalignant Diseases: End of the Beginning and Future Challenges
|
Satwani, Prakash |
|
2005 |
11 |
6 |
p. 403-422 20 p. |
artikel |
11 |
Reduced-Intensity Conditioning Allogeneic Blood Stem Cell Transplantation with Fludarabine and Oral Busulfan with or without Pharmacokinetically Targeted Busulfan Dosing in Patients with Myeloid Leukemia Ineligible for Conventional Conditioning
|
Martino, Rodrigo |
|
2005 |
11 |
6 |
p. 437-447 11 p. |
artikel |
12 |
Table of contents 2
|
|
|
2005 |
11 |
6 |
p. A12- 1 p. |
artikel |
13 |
Table of contents 1
|
|
|
2005 |
11 |
6 |
p. A11- 1 p. |
artikel |
14 |
The Effects of Interleukin 10 and Interferon γ Cytokine Gene Polymorphisms on Survival after Autologous Bone Marrow Transplantation for Patients with Breast Cancer
|
Wu, Julie M. |
|
2005 |
11 |
6 |
p. 455-464 10 p. |
artikel |